Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells

Respiratory Physiology and Neurobiology

Volumn 185, Issue 2, 2013, Pages 332-338

  Zeng, Jing ^a,b   Yi, Bin ^a   Wang, Zhi ^a   Ning, Jiaolin ^a   Wang, Xiaobin ^b   Lu, Kaizhi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Annexin A2; Hepatopulmonary syndrome; Proliferation; Pulmonary arterial smooth muscle cells

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BILE DUCT LIGATION; CELL PROLIFERATION; COMMON BILE DUCT; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HEPATOPULMONARY SYNDROME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PULMONARY ARTERY; RAT; SERUM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; ANNEXIN A2; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HEPATOPULMONARY SYNDROME; MALE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RNA, SMALL INTERFERING; SERUM; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TETRAZOLIUM SALTS; THIAZOLES; THYMIDINE; TRANSFECTION;

EID: 84871919489     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.09.009     Document Type: Article

References (40)

1. Bao H.Y., Jiang M., Zhu M.Q., Sheng F., Ruan J., Ruan C.G. Overexpression of annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. International Journal of Hematology 2009, 90:177-185.
2. Chiang Y., Schneiderman M.H., Vishwanatha J.K. Annexin II expression is regulated during mammalian cell cycle. Cancer Research 1993, 53:6017-6021.
3. El-Swefy S., Hassanen S.I. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats. Annals of Hepatology 2009, 8:41-49.
4. Eustace A.J., Dowling P., Henry M., Doolan P., Meleady P., Clynes M., Crown J., O'Donovan N. 2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell lines. Journal of Proteomics 2011, 74:490-501.
5. Gaines D.I., Fallon M.B. Hepatopulmonary syndrome. Liver International 2004, 24:397-401.
6. Grewal T., Enrich C. Annexins - modulators of EGF receptor signalling and trafficking. Cellular Signalling 2009, 21:847-858.
7. Guzman-Aranguez A., Olmo N., Turnay J., Lecona E., Perez-Ramos P., de Silanes I.P., Lizarbe M.A. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. Journal of Cellular Biochemistry 2005, 94:178-193.
8. Huang Y., Jin Y., Yan C.H., Yu Y., Bai J., Chen F., Zhao Y.Z., Fu S.B. Involvement of Annexin A2 in p53 induced apoptosis in lung cancer. Molecular and Cellular Biochemistry 2008, 309:117-123.
9. Ibe B.O., Abdallah M.F., Portugal A.M., Raj J.U. Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases. Cell Proliferation 2008, 41:208-229.
10. Illien F., Finet S., Lambert O., Ayala-Sanmartin J. Different molecular arrangements of the tetrameric annexin 2 modulate the size and dynamics of membrane aggregation. Biochimica Et Biophysica Acta: Biomembranes 2010, 1798:1790-1796.
11. Krutilina R.I., Babich V.S., Kropotov A.V., Mudrak O.S., Chesnokov I.N., Turoverova L.V., Konstantinova I.M., Tomilin N.V. The DNA-binding activity of the membrane protein annexin II and its interaction with antibodies to the chromatin nuclear ribonucleoprotein (alpha-RNP). Tsitologiia 1996, 38:1106-1114.
12. Kumble K.D., Hirota M., Pour P.M., Vishwanatha J.K. Enhanced levels of annexins in pancreatic carcinoma cells of syrian hamsters and their intrapancreatic allografts. Cancer Research 1992, 52:163-167.
13. Li B., Yang L., Shen J., Wang C., Jiang Z. The anti proliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via Upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation. Anesthesia and Analgesia 2007, 105:1034-1041.
14. Li G.W., Xing W.J., Bai S.Z., Hao J.H., Guo J., Li H.Z., Li H.X., Zhang W.H., Yang B.F., Wu L.Y., Wang R., Yang G.D., Xu C.Q. The calcium-sensing receptor mediates hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells through MEK1/ERK1,2 and PI3K pathways. Basic and Clinical Pharmacology and Toxicology 2011, 108:185-193.
15. 2+ channels in pulmonary arterial smooth muscle cells - a novel mechanism of hypoxic pulmonary hypertension. Circulation Research 2004, 95:496-505.
16. Liu J., Vishwanatha J.K. Regulation of nucleo-cytoplasmic shuttling of human annexin A2-a proposed mechanism. Molecular and Cellular Biochemistry 2007, 303:211-220.
17. Liu Y.F., Xiao Z.Q., Zhang P.F., Li M.Y., Li C., Peng F., Yu Y.H., Yi H., Chen Z.C. Quantitative proteomic analysis of metastasis-associated proteins in human primary lung adenocarcinoma. Progress in Biochemistry and Biophysics 2009, 36:448-457.
18. Longerich T., Haller M.T., Mogler C., Aulmann S., Lohmann V., Schirmacher P., Brand K. Annexin A2 as a differential diagnostic marker of hepatocellular tumors. Pathology Research and Practice 2011, 207:8-14.
19. Luo C.X., Yi B., Bai L., Xia Y.Z., Wang G.S., Qian G.S., Feng H. Suppression of Akt1 phosphorylation by adenoviral transfer of the PTEN gene inhibits hypoxia-induced proliferation of rat pulmonary arterial smooth muscle cells. Biochemical and Biophysical Research Communications 2010, 397:486-492.
20. Luo W., Yan G.R., Li L.L., Wang Z.L., Liu H.D., Zhou S.H., Liu S.F., Tang M., Yi W., Dong Z.G., Cao Y. Epstein-Barr virus latent membrane protein 1 mediates serine 25 phosphorylation and nuclear entry of annexin A2 via PI-PLC-PKC alpha/PKC beta pathway. Molecular Carcinogenesis 2008, 47:934-946.
21. Mohammad H.S., Kurokohchi K., Yoneyama H., Tokuda M., Morishita A., Jian G., Shi L., Murota M., Tani J., Kato K., Miyoshi H., Deguchi A., Himoto T., Usuki H., Wakabayashp H., Izuishi K., Suzuki Y., Iwama H., Deguchi K., Uchida N., Sabet E.A., Arafa U.A., Hassan A.A., Masaki T., El-Sayed A.A. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. International Journal of Oncology 2008, 33:1157-1163.
22. Monastyrskaya K., Tschumi F., Babiychuk E.B., Stroka D., Draeger A. Annexins sense changes in intracellular pH during hypoxia. Biochemical Journal 2008, 409:65-75.
23. Ogawa A., Firth A.L., Yao W.J., Rubin L.J., Yuan J.X.J. Prednisolone inhibits PDGF-induced nuclear translocation of NF-kappa B in human pulmonary artery smooth muscle cells. American Journal of Physiology: Lung Cellular and Molecular Physiology 2008, 295:L648-L657.
24. Ono M., Sawa Y., Mizuno S., Fukushima N., Ichikawa H., Bessho K., Nakamura T., Matsuda H. Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats. Circulation 2004, 110:2896-2902.
25. Ortiz-Zapater E., Peiro S., Roda O., Corominas J.M., Aguilar S., Ampurdanes C., Real F.X., Navarro P. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. American Journal of Pathology 2007, 170:1573-1584.
26. Rescher U., Gerke V. Annexins - unique membrane binding proteins with diverse functions. Journal of Cell Science 2004, 117:2631-2639.
27. Rodriguez-Roisin R., Krowka M.J., Herve P., Fallon M.B. Pulmonary-hepatic vascular disorders (PHD). European Respiratory Journal 2004, 24:861-880.
28. Rodriguez-Roisin R., Krowka M.J. Current concepts: hepatopulmonary syndrome - a liver-induced lung vascular disorder. New England Journal of Medicine 2008, 358:2378-2387.
29. Sarkar S., Swiercz R., Kantara C., Hajjar K.A., Singh P. Annexin A2 mediates up-regulation of NF-kappa B, beta-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology 2011, 140:U312-U583.
30. Schmitz K.J., Wohlschlaeger J., Lang H., Sotiropoulos G.C., Malago M., Steveling K., Reis H., Cicinnati V.R., Schmid K.W., Baba H.A. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. Journal of Hepatology 2008, 48:83-90.
31. Seth D., Leo M.A., McGuinness P.H., Lieber C.S., Brennan Y., Williams R., Wang X.M., McCaughan G.W., Gorrell M.D., Haber P.S. Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver. American Journal of Pathology 2003, 163:2303-2317.
32. Spagnolo P., Zeuzem S., Richeldi L., du Bois R.M. The complex interrelationships between chronic lung and liver disease: a review. Journal of Viral Hepatitis 2010, 17:381-390.
33. Stenmark K.R., Fagan K.A., Frid M.G. Hypoxia-induced pulmonary vascular remodeling - cellular and molecular mechanisms. Circulation Research 2006, 99:675-691.
34. Thenappan T., Goel A., Marsboom G., Fang Y.H., Toth P.T., Zhang H.J., Kajimoto H., Hong Z.G., Paul J., Wietholt C., Pogoriler J., Piao L., Rehman J., Archer S.L. A Central role for CD68(+) macrophages in hepatopulmonary syndrome reversal by macrophage depletion. American Journal of Respiratory and Critical Care Medicine 2011, 183:1080-1091.
35. Tieppo J., Cuevas M.J., Vercelino R., Tunon M.J., Marroni N.P., Gonzalez-Gallego J. Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. Journal of Nutrition 2009, 139:1339-1346.
36. Yan G.R., Luo W., Lu Z.X., Luo X.J., Li L.L., Liu S.F., Liu Y.P., Tang M., Dong Z.G., Cao Y. Epstein-Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway. Cellular Signalling 2007, 19:341-348.
37. Yi B., Cui J., Ning J., Gu J., Wang G., Bai L., Qian G., Lu K. cGMP-dependent protein kinase Ialpha transfection inhibits hypoxia-induced migration, phenotype modulation and annexins A1 expression in human pulmonary artery smooth muscle cells. Biochemical and Biophysical Research Communications 2012, 418:598-602.
38. Yi B., Cui J., Ning J.N., Wang G.S., Qian G.S., Lu K.Z. Over-expression of PKGIalpha inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling. Gene 2012, 492:354-360.
39. Zaiman A.L., Podowski M., Medicherla S., Gordy K., Xu F., Zhen L.J., Shimoda L.A., Neptune E., Higgins L., Murphy A., Chakravarty S., Protter A., Sehgal P.B., Champions H.C., Tuder R.M. Role of the TGF-beta/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2008, 177:896-905.
40. Zhang J.L., Luo B., Tang L.P., Wang Y.M., Stockard C.R., Kadish I., Van Groen T., Grizzle W.E., Ponnazhagan S., Fallon M.B. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 2009, 136:1070-1080.